Haemonetics Corp.

NYSE:HAE

76.87

+0.63 (+0.83%)

4:04:16 PM EDT: $73.00 -3.87 (-5.03%)

Market Cap (Intraday)	3.72B
Current PE	22.20
Forward PE	15.85
2yr Forward PE	13.68

See more stats

Estimates Current Quarter

Revenue	$303.37 Million
Adjusted EPS	$1.01

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Haemonetics Corp. Stock, NYSE:HAE

125 Summer Street, Boston, Massachusetts 02110

United States of America

Phone: +1.781.848.7100

Number of Employees: 3657

http://www.haemonetics.com

Description

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.